Agusti, Alvar, Barnes, Neil, Papi, Alberto, Pavord, Ian D., Thomas, Mike, Walker, Samantha, Yates, Louisa, Cruz, Alvaro A., Gibson, Peter G., Heaney, Liam G., Inoue, Hiromasa, Leather, David, Martinez, Fernando J., McDonald, Vanessa M., Oppenheimer, John. Elsevier; 2021. Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.

Pavord, Ian D., Beasley, Richard, Frey, Urs, Gibson, Peter, Heaney, Liam G., Holt, Patrick G., Humbert, Marc, Lloyd, Clare M., Marks, Guy, Martinez, Fernando D., Sly, Peter D., von Mutius, Erika, Agusti, Alvar, Wenzel, S, Zar, HJ, Bush, A, Anderson, Gary P., Bel, Elisabeth, Brusselle, Guy, Cullinan, Paul, Custovic, Adnan, Ducharme, Francine M., Fahy, John V.. Elsevier; 2018. After asthma: redefining airways diseases.

Obeidat, Ma’en, Dvorkin-Gheva, Anna, Stampfli, Martin R., Sin, Don D., Li, Xuan, Bosse, Yohan, Brandsma, Corry-Anke, Nickle, David C., Hansbro, Philip M., Faner, Rosa, Agusti, Alvar, Pare, Peter D.. Nature Publishing Group; 2018. The overlap of lung tissue transcriptome of smoke exposed mice with human smoking and COPD.

McDonald, Vanessa M., Treatable Traits Down Under International Workshop participants, Fingleton, James, Wark, Peter A. B., Gibson, Peter G., , Agusti, Alvar, Hiles, Sarah A., Clark, Vanessa L., Holland, Anne E., Marks, Guy B., Bardin, Philip P., Beasley, Richard, Pavord, Ian D.. European Respiratory Society; 2019. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report.

Hiles, Sarah A., Gibson, Peter G., Agusti, Alvar, McDonald, Vanessa M.. Elsevier; 2021. Treatable Traits That Predict Health Status and Treatment Response in Airway Disease.

Mathioudakis, Alexander G., Abroug, Fekri, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard J., Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Fernandez Romero, Gustavo, Agusti, Alvar, McDonald, Vanessa M., Horváth, P, Huerta Garcia, A, Jacobs, M, Jenkins, C, Joos, G, Kharevich, O, Kostikas, K, Lapteva, E, Lazar, Z, Ananth, Sachin, Leuppi, JD, Liddle, C, Linnell, J, López-Giraldo, A, McDonald, VM, Nielsen, R, Papi, A, Saraiva, I, Sergeeva, G, Sioutkou, A, Bakke, Per, Sivapalan, P, Stovold, E, Wang, H, Wen, F, Yorke, J, Williamson, PR, Vestbo, J, Jensen, J-U, DECODE-NET,, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy. European Respiratory Society; 2022. ERS statement: A core outcome set for clinical trials evaluating the management of COPD exacerbations.

Agusti, Alvar, Bel, Elisabeth, Beasley, Richard, Pavord, Ian D., Thomas, Mike, Vogelmeier, Claus, Brusselle, Guy, Holgate, Stephen, Humbert, Marc, Jones, Paul, Gibson, Peter G., Vestbo, Jørgen. European Respiratory Society; 2016. Treatable traits: toward precision medicine of chronic airway diseases.

Stolz, Daiana, Mkorombindo, Takudzwa, Franssen, Frits M. E., Frey, Urs, Han, MeiLan, Hansel, Nadia N., Hawkins, Nathaniel M., Kalhan, Ravi, Konigshoff, Melanie, Ko, Fanny W., Parekh, Trisha M., Powell, Pippa, Schumann, Desiree M., Rutten-van Mölken, Maureen, Simpson, Jodie, Sin, DD, Song, Y, Suki, B, Troosters, T, Washko, GR, Welte, T, Dransfield, MT, Agusti, Alvar, Ash, Samuel Y., Bafadhel, Mona, Bai, Chunxue, Chalmers, James D., Criner, Gerard J., Dharmage, Shyamali C.. The Lancet Publishing Group; 2022. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.

Agusti, Alvar, Gibson, Peter G., McDonald, Vanessa M.. Elsevier; 2023. Treatable Traits in Airway Disease: From Theory to Practice.

Papi, Alberto, Faner, Rosa, Pavord, Ian, Baraldi, Federico, McDonald, Vanessa M., Thomas, Mike, Miravitlles, Marc, Roche, Nicholas, Agusti, Alvar. European Respiratory Society; 2024. From treatable traits to GETomics in airway disease: moving towards clinical practice.

McDonald, Vanessa M., Hamada, Yuto, Agusti, Alvar, Gibson, Peter G.. Elsevier; 2024. Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety.